These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 9381967)
21. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease. Bame KJ; Danda J; Hassall A; Tumova S J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014 [TBL] [Abstract][Full Text] [Related]
22. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. Nakajima M; Irimura T; Di Ferrante N; Nicolson GL J Biol Chem; 1984 Feb; 259(4):2283-90. PubMed ID: 6698965 [TBL] [Abstract][Full Text] [Related]
23. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. Marchetti D; Li J; Shen R Cancer Res; 2000 Sep; 60(17):4767-70. PubMed ID: 10987284 [TBL] [Abstract][Full Text] [Related]
24. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275 [TBL] [Abstract][Full Text] [Related]
26. The interaction between basic fibroblast growth factor and heparan sulfate can prevent the in vitro degradation of the glycosaminoglycan by Chinese hamster ovary cell heparanases. Tumova S; Bame KJ J Biol Chem; 1997 Apr; 272(14):9078-85. PubMed ID: 9083034 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522 [TBL] [Abstract][Full Text] [Related]
29. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion. Aucoin R; Reiland J; Roy M; Marchetti D J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349 [TBL] [Abstract][Full Text] [Related]
30. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400 [TBL] [Abstract][Full Text] [Related]
31. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578 [TBL] [Abstract][Full Text] [Related]
38. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate. Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189 [TBL] [Abstract][Full Text] [Related]
39. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287 [TBL] [Abstract][Full Text] [Related]
40. p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. Marchetti D; Aucoin R; Blust J; Murry B; Greiter-Wilke A J Cell Biochem; 2004 Jan; 91(1):206-15. PubMed ID: 14689592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]